Grantham, Mayo, Van Otterloo & Co (GMO)’s Crocs CROX Stock Holding History
Bought
Maintained
Sold
Other funds holding CROX
Grantham, Mayo, Van Otterloo & Co (GMO)'s CROX Position: Q2 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Crocs (CROX) stake by 45% in Q2 2026, selling an estimated $3.34M and leaving 37,757 shares worth $4.56M. The position accounts for 0.01% of the portfolio, ranked #342.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CROX in Q1 2020 and has held it in 12 quarters since. The position peaked at $9.32M in Q2 2024. 502 funds tracked by Wall St. Rank hold CROX as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 37,757 shares of Crocs worth $4.56M as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 30,567 Crocs shares in Q2 2026, an estimated $3.34M.
- Crocs made up 0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #342 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Crocs in Q1 2020 and has held it in 12 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Crocs position peaked at $9.32M in Q2 2024.
- 502 funds tracked by Wall St. Rank held Crocs as of Q2 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.